An efficient design for phase III studies of combination chemotherapies.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011336:Probability; D011897:Random Allocation; D012107:Research Design; D012494:Sampling Studies; D013223:Statistics as Topic